2021 Global Conference Coverage: An Update on the Clinical Development Across Gynecologic Malignancies*

Download All
The 2021 SGO Virtual Annual Meeting, 19-25 March 2021, in Seattle, Washington, USA; The 2021 ASCO Annual Meeting, 4-8 June 2021, in Chicago, Illinois, USA; The 2021 IGCS Meeting, 30 August - 2 September, in Rome, Italy; The ESMO 2021 Annual Congress, 17-21 September 2021, in Paris, France; The 2021 ESGO Conference, 23-26 October 2021, in Prague, Czech Republic

Read or listen to 5 expert commentaries providing global perspectives on emerging data in ovarian and endometrial cancers presented at the 2021 meetings of SGO, ASCO, IGCS, ESMO, and ESGO, and then download the slideset with all the key data.

This educational program is intended for clinicians practicing medicine outside of the United States.

Jubilee Brown, MD
Nicole Concin, MD, PhD
Bernard Doger de Spéville, MD, PhD
Melissa M. Hardesty, MD, MPH
person default
Alexandra Leary, MD, PhD
Domenica Lorusso, MD, PhD
Ursula Matulonis, MD
David Scott Miller, MD, FACOG, FACS
Prof Isabelle Ray-Coquard, MD, PhD

Downloadable Slideset

Download this “living” summary slideset covering new data from key studies in gynecologic cancers as they are presented at different conferences throughout 2021.

This educational activity is intended for clinicians practicing medicine outside of the United States.

Jubilee Brown, MD Nicole Concin, MD, PhD Bernard Doger de Spéville, MD, PhD Melissa M. Hardesty, MD, MPH person default Alexandra Leary, MD, PhD Domenica Lorusso, MD, PhD Ursula Matulonis, MD David Scott Miller, MD, FACOG, FACS Prof Isabelle Ray-Coquard, MD, PhD Released: November 15, 2021

ClinicalThought

How do you currently address management challenges in patients with endometrial and ovarian cancers? Read our thoughts on how we currently approach challenges with novel therapies for the treatment of endometrial and ovarian cancers.

This ClinicalThought is intended for clinicians practicing medicine outside of the United States.

Jubilee Brown, MD Ursula Matulonis, MD Released: May 3, 2021

Gynecologic oncology experts share their thoughts on notable new data presented at the 2021 ASCO annual meeting for the treatment of endometrial, ovarian, and cervical cancers.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

Melissa M. Hardesty, MD, MPH David Scott Miller, MD, FACOG, FACS Released: July 8, 2021

Gynecologic oncology experts share their takeaways from new clinical data presented at the 2021 IGCS annual meeting for the treatment of endometrial, ovarian, and cervical cancers.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

person default Alexandra Leary, MD, PhD Domenica Lorusso, MD, PhD Released: September 30, 2021

Read this commentary from Prof Isabelle Ray-Coquard, MD, PhD, and Bernard Doger de Spéville, MD, PhD, on the current status and application of actionable biomarkers for ovarian and endometrial cancers in Europe.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

Bernard Doger de Spéville, MD, PhD Prof Isabelle Ray-Coquard, MD, PhD Released: October 8, 2021

Podcasts

In this podcast episode, listen to David Scott Miller, MD, FACOG, FACS, and Melissa M. Hardesty, MD, MPH, discuss new data for gynecologic cancers presented at the virtual ASCO 2021 annual meeting, including novel data for single-agent immunotherapy in patients with endometrial cancer, data for novel agents targeting the folate receptor-α in ovarian cancer, and data for a novel bifunctional fusion proteins cotargeting the TGF-β receptor and PD-L1 pathways in cervical cancers.

Melissa M. Hardesty, MD, MPH David Scott Miller, MD, FACOG, FACS Released: June 24, 2021

In this podcast episode, listen to Prof. Isabelle Ray-Coquard, MD, PhD, and Bernard Doger de Spéville, MD, PhD, discuss important new clinical trial data for endometrial and ovarian cancers presented at the virtual ESMO 2021 annual meeting.

Bernard Doger de Spéville, MD, PhD Prof Isabelle Ray-Coquard, MD, PhD Released: September 29, 2021

In this podcast episode, listen to Nicole Concin, MD, PhD, as she highlights important clinical trial data for ovarian and endometrial cancers presented at the ESGO 2021 annual meeting.

Nicole Concin, MD, PhD Released: November 23, 2021

In this podcast episode, listen to Ursula Matulonis, MD, and Jubilee Brown, MD, discuss new data for gynecological cancers presented at the virtual SGO 2021 meeting, including immunotherapy-based combinations for endometrial cancer and PARP inhibitors for BRCA-mutated ovarian cancers.

This podcast is intended for clinicians practicing medicine outside of the United States.

Jubilee Brown, MD Ursula Matulonis, MD Released: April 7, 2021

In this podcast episode, listen to Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, discuss practice‑changing data for gynecologic cancers presented at the virtual IGCS 2021 annual meeting, including novel data for single-agent and combination immunotherapy in patients with endometrial and cervical cancers, subanalyzes of exceptional responders to PARP inhibitors in ARIEL3, and timing for initiation of PARP inhibitor maintenance from the NORA trial.

person default Alexandra Leary, MD, PhD Domenica Lorusso, MD, PhD Released: September 21, 2021

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue